Details view: Adverse impact on patient-safety

Views
Add
Edit
- Edit page
- Delete page
Share
Login
- Member login
- Register now for a free account
🔎

Adverse impact on patient-safety OpposingArgument1 #113933 High proportions of false-positive and false-negative results adversely impact patient safety.

CONTEXT(Help)

Controlling Infectious Diseases »Controlling Infectious DiseasesControlling Infectious Diseases☜Mapping the issues around endemic diseases—such as malaria, measles, influenza, HIV, Dengue and West Nile Virus—with the aims of identifying improved control strategies and of providing insights into to the work of mathematical biologists, epidemiologists and public health officials in this field.☜F1CEB7

▲

Diseases »DiseasesDiseases☜☜FFB597

▲

TB »TBTB☜The Wikipedia page on Tuberculosis is embedded in the Details, and will be updated whenever the Wikipedia page updates.☜D3B8AB

▲

Diagnosis of Tuberculosis »Diagnosis of TuberculosisDiagnosis of Tuberculosis☜☜FFB597

▲

Commercial Serological Tests for TB »Commercial Serological Tests for TBCommercial Serological Tests for TB☜☜59C6EF

■

Adverse impact on patient-safetyAdverse impact on patient-safety☜High proportions of false-positive and false-negative results adversely impact patient safety.☜EF597B

Heading

Summary

Click the button to enter task scheduling information

Details

Enter task details

Message text

Select assignee(s)

Due date (click calendar)

RadDatePicker

Open the calendar popup.

Calendar

Title and navigation
Title and navigation
<<	<	July 2024	>	<<

July 2024
	S	M	T	W	T	F	S
27	30	1	2	3	4	5	6
28	7	8	9	10	11	12	13
29	14	15	16	17	18	19	20
30	21	22	23	24	25	26	27
31	28	29	30	31	1	2	3
32	4	5	6	7	8	9	10

Reminder

Ready to post Copy to text

Task assignment(s) have been emailed and cannot now be altered

Lock

Comment graphing options

Choose comments:Comment onlyWhole threadAll comments

Choose location:To a new mapTo this map

New map options

Select map ontology Graph to private map

+Comments (0)

- CommentsAdd a commentNewest firstOldest firstShow threads

+Citations (1)

- CitationsAdd new citationList by: CiterankMap

Link[1] Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis

Author: World Health Organization - WHO Policy Statement – 2011
Cited by: David Price 9:31 PM 22 July 2011 GMT

Citerank: (7) 113930Inconsistent findingsCommercial serological tests for TB provide findings13EF597B, 113931Imprecise findingsCommercial serological tests for TB provide imprecise findings.13EF597B, 113932Patient-important outcomes aren't improvedThere is no evidence that existing commercial serological assays improve patient-important outcomes.13EF597B, 129647Inconsistent findingsCommercial serological tests for TB provide findings13EF597B, 129648Imprecise findingsCommercial serological tests for TB provide imprecise findings.13EF597B, 129649Patient-important outcomes aren't improvedThere is no evidence that existing commercial serological assays improve patient-important outcomes.13EF597B, 129650Adverse impact on patient-safetyHigh proportions of false-positive and false-negative results adversely impact patient safety.13EF597B

URL:

http://whqlibdoc.who.int/publications/2011/9789241502054_eng.pdf

Excerpt / Summary

Conclusions: Commercial serological tests provide inconsistent and imprecise findings resulting in highly variable values for sensitivity and specificity. There is no evidence that existing commercial serological assays improve patient-important outcomes, and high proportions of false positive and false-negative results adversely impact patient safety. Overall data quality was graded as very low and it is strongly recommended that these tests not be used for the diagnosis of pulmonary and extra-pulmonary TB.

+About

- About

Entered by:- David Price
NodeID: #113933
Node type: OpposingArgument
Entry date (GMT): 7/22/2011 9:30:00 PM
Last edit date (GMT): 7/22/2011 9:30:00 PM
Show other editors
Incoming cross-relations: 0
Outgoing cross-relations: 0
Average rating: 0 by 0 users

x Select file to upload